Personalis, Inc. Accumulated Other Comprehensive Income
Personalis, Inc. (PSNL) had Accumulated Other Comprehensive Income of -$118.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$118.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$70.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $104.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $82.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$118.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | -$70.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $104.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $82.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $20.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | -$18.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | -$23.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $87.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$120.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$125.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$222.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | -$302.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$313.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$455.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | -$912.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | -$1.42M 10-Q · filed 2022-11-02 |
| 2022-06-30 | -$1.26M 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$875.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$166.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | $12.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $18.00K 10-Q · filed 2021-08-04 |
| 2021-03-31 | -$5.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $22.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $37.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $106.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $73.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$6.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | -$29.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$15.00K 10-Q · filed 2019-08-13 |
| 2018-12-31 | -$15.00K 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |